The Biotech Deal That Became a Leadership Crisis | Philip Borden (3/4)
Philip Borden describes leaving Frazier Healthcare Partners for Harvard Business School, where the case method broadened his perspective beyond healthcare and investing. He explains why he returned to healthcare investing after graduation.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from The Biotech Startups Podcast
Leaving Merck to Build a Biotech From Scratch | Örn Almarsson (2/4)
How a Guitarist Became a Drug Delivery Pioneer | Örn Almarsson (1/4)
Don't Build Your Own Cathedral: The Hidden Cost of Lab Space | Philip Borden (4/4)
Cold Calling Your Way Into Venture Capital | Philip Borden (2/4)
Get summaries like this every morning.
Free AI-powered recaps of The Biotech Startups Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.